Sherman Michael A.
SEC insider (Form 3/4/5 filer). CIK 0001509463. Director at Aktis Oncology, Inc. (AKTS) and 2 other issuers. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2025. Located in BOSTON, MA.
Companies Sherman Michael A. has filed insider reports for
- Aktis Oncology, Inc. (AKTS): Director
- Werewolf Therapeutics, Inc. (HOWL): Director
- CHIMERIX INC (CMRX): Director, Officer, Chief Executive Officer
Sherman Michael A.
CIK: 0001509463
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (75.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 12, 2025HOWL
Werewolf Therapeutics, Inc.
AwardDirectStock Option (right to buy)
27K shares- - Apr 21, 2025CMRX
CHIMERIX INC
DispositionIndirect87K shares at avg. $8.55$744K - Apr 21, 2025CMRX
CHIMERIX INC
DispositionIndirect103K shares at avg. $8.55$881K - Apr 21, 2025CMRX
CHIMERIX INC
DispositionDirect233.4K shares at avg. $8.55$2.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2025 |  HOWL Werewolf Therapeutics, Inc. | Award Stock Option (right to buy) | 27,000 | - | - | Direct |
| Apr 21, 2025 |  CMRX CHIMERIX INC | Disposition | 87,000 | $8.55 | $743,850 | Indirect |
| Apr 21, 2025 | CMRX CHIMERIX INC | Disposition | 102,995 | $8.55 | $880,607 | Indirect |
| Apr 21, 2025 | CMRX CHIMERIX INC | Disposition | 233,413 | $8.55 | $1,995,681 | Direct |
1-4 of 4 transactions